Insufficient scRNA-seq data for expression of SPINDOC at single-cell level.
Insufficient scRNA-seq data for expression of SPINDOC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1320.08 | 180 / 180 | 100% | 44.84 | 430 / 430 |
brain | 100% | 1076.40 | 2635 / 2642 | 100% | 28.40 | 705 / 705 |
prostate | 100% | 1608.29 | 245 / 245 | 99% | 24.23 | 498 / 502 |
thymus | 100% | 1218.47 | 653 / 653 | 99% | 24.41 | 600 / 605 |
uterus | 100% | 1727.25 | 170 / 170 | 99% | 48.31 | 455 / 459 |
skin | 99% | 723.80 | 1792 / 1809 | 100% | 44.08 | 472 / 472 |
bladder | 100% | 1637.71 | 21 / 21 | 99% | 38.79 | 498 / 504 |
breast | 100% | 837.69 | 459 / 459 | 99% | 30.91 | 1103 / 1118 |
lung | 100% | 1394.12 | 578 / 578 | 99% | 38.07 | 1138 / 1155 |
intestine | 100% | 1283.66 | 964 / 966 | 98% | 29.22 | 516 / 527 |
stomach | 100% | 802.92 | 359 / 359 | 97% | 29.22 | 277 / 286 |
esophagus | 100% | 1194.03 | 1445 / 1445 | 97% | 25.81 | 177 / 183 |
kidney | 100% | 989.43 | 89 / 89 | 95% | 17.13 | 854 / 901 |
adrenal gland | 100% | 814.56 | 258 / 258 | 94% | 28.29 | 216 / 230 |
pancreas | 93% | 360.62 | 305 / 328 | 99% | 25.97 | 176 / 178 |
liver | 53% | 164.05 | 120 / 226 | 55% | 9.47 | 223 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 24.49 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 45.81 | 29 / 29 |
spleen | 100% | 1151.53 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 32.24 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 40.90 | 1 / 1 |
blood vessel | 100% | 1122.25 | 1333 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 862.47 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 817.06 | 856 / 861 | 0% | 0 | 0 / 0 |
muscle | 93% | 351.85 | 745 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 71% | 712.05 | 656 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010835 | Biological process | regulation of protein ADP-ribosylation |
GO_0006974 | Biological process | DNA damage response |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0090734 | Cellular component | site of DNA damage |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | SPINDOC |
Protein name | Spindlin interactor and repressor of chromatin-binding protein (SPIN1-docking protein) (SPIN-DOC) Spindlin interactor and repressor of chromatin binding |
Synonyms | C11orf84 |
Description | FUNCTION: Negatively regulates the transcriptional activator activity of SPIN1 via inhibition of its histone methyl-binding ability . Represses the expression of a number of SPIN1-regulated genes and the SPIN1-mediated activation of the Wnt signaling pathway . Can also inhibit the histone methyl-binding abilities of SPIN2A, SPIN2B, SPIN3 and SPIN4 . Positively regulates poly-ADP-ribosylation in response to DNA damage; acts by facilitating PARP1 ADP-ribosyltransferase activity . . |
Accessions | ENST00000540893.1 Q9BUA3 ENST00000535820.1 H0YGK9 H0YGY5 ENST00000294244.9 |